Skip to main content

Table 1 Complication rates of talc insufflation for MPEs

From: Complications of thoracoscopic talc insufflation for the treatment of malignant pleural effusions: a meta-analysis

Complication

Number of studies

Number of cases

Total patients

Incidence [95% CI]

p-value

Pain

8

165

1378

20 [8, 37]

< 0.001

Fever

11

190

1574

14 [7, 23]

< 0.001

Pneumothorax

3

29

461

6 [1, 14]

< 0.001

Pneumonia

6

52

1058

4 [0, 12]

0.02

Emphysema

6

54

1577

3 [1, 7]

< 0.001

Prolonged air leakage

5

57

1661

3 [0, 7]

0.01

Prolonged drainage

2

26

823

3 [2, 4]

< 0.001

Thromboembolism

2

17

496

3 [2, 5]

< 0.001

Nausea/vomiting

3

5

234

2 [0, 5]

0.04

Respiratory insufficiency

3

5

178

2 [0, 5]

0.02

Hypotension

2

5

188

2 [0, 5]

0.01

Lung injury

3

11

704

2 [1, 3]

< 0.001

Pulmonary embolism

4

14

828

2 [0, 4]

0.02

Arrythmia

6

20

828

2 [0, 4]

< 0.001

Empyema

11

28

1883

1 [0, 2]

< 0.001

Wound infection

5

15

1240

1 [0, 2]

< 0.001

Renal dysfunction

2

6

401

1 [0, 3]

< 0.001

Re-expansion pulmonary edema

5

18

1188

1 [0, 3]

0.01

Respiratory failure

7

13

1863

0 [0, 1]

0.24

Acute respiratory distress syndrome

14

27

2889

0 [0, 1]

0.36

Bleeding

7

13

2148

0 [0, 1]

< 0.001

Tumor recurrence at port

2

4

428

0 [0, 1]

0.17

Myocardial infarction

3

5

1253

0 [0, 1]

< 0.001

Pulmonary edema

3

3

561

0 [0, 2]

0.44